Build or Buy: How to Decide Who Runs Your GenAI Annotation Pipeline

Most teams frame this as a cost comparison: a labeling platform license and a few contractors versus a vendor invoice. That framing misses the actual decision, which is about capability ownership — what your team needs to control directly, and what it can responsibly hand to someone else.

Both paths cost real money. The difference is where the cost shows up and how predictable it is.

What "build" actually includes

An in-house annotation function is rarely just annotators. It typically includes:

• Recruiting and management — sourcing, vetting and supervising a labeling team, or hiring a manager to do it
• Tooling — a labeling platform license, or engineering time to build one
• Taxonomy design — defining classes, edge cases and decision rules before anyone can label consistently
• A QA layer — someone has to measure inter-annotator agreement, review disagreement and maintain a gold set
• Ramp and attrition — every new annotator needs training, and every departure resets part of that investment

None of these show up as a single line item. They show up as a slower first batch, a taxonomy that drifts without anyone noticing, or a quality problem discovered at model evaluation instead of at the labeling stage.

Neither column is universally better. The right side of the table depends on your volume shape, your timeline and how much of this work is actually core to what you're building.

Why this decision carries more weight than it looks like

Gartner has predicted that through 2026, organizations will abandon 60% of AI projects that are not supported by AI-ready data, and a Q3 2024 Gartner survey found that 63% of data management leaders either lacked the right data practices for AI or were unsure whether they had them.[1] Most of that risk sits upstream of the model — in whether the data pipeline feeding it is disciplined, measured and maintained.

A build-or-buy decision made casually, without accounting for QA and taxonomy ownership, is one of the more common ways that risk enters a project.

When building in-house is the right call

Building makes sense when the annotated data itself is a durable part of your moat — not just an input to one model, but a proprietary asset you'll keep refining for years. It also fits teams with volume that is large, steady and predictable enough to justify permanent headcount, and organizations that already have spare ML-adjacent infrastructure and the management bandwidth to run a QA discipline properly, not as a side responsibility.

If those conditions hold, the fixed cost of an in-house team amortizes well, and you keep full control of the taxonomy as it evolves.

When buying is the right call

Buying tends to fit teams earlier in that curve: volume that is lumpy or still being discovered, a need to see labeled data in days rather than months, a task that requires domain expertise the team doesn't have in-house, and a stage where a permanent ops function isn't yet justified by the roadmap.

McKinsey's State of AI 2026 survey found that 32% of organizations have opted to build rather than buy AI-related software, using agentic coding tools — and that share rises to nearly half among the highest-performing organizations.[2] That trend is real, but it describes software tooling. Annotation is an ongoing human-review discipline, not a one-time build: the taxonomy keeps shifting, edge cases keep appearing, and someone has to keep measuring agreement. That's a different kind of commitment than shipping a tool once.

The real question isn't build or buy — it's who owns quality when volume changes

Volume rarely stays flat. A team that builds in-house for a steady 50,000 labels a month can find itself needing 200,000 the next quarter, or dropping to near zero between training runs. The team that owns this decision well is the one that has planned for both directions, not just the current volume.

That's also where a hybrid model often ends up making the most sense: a lean internal team that owns the taxonomy and gold set, paired with flexible outside capacity for the labeling volume itself. You keep the judgment calls in-house and let capacity flex with demand.